How much dividend does Rezolute pay?
Over the past 12 months, Rezolute paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Rezolute is expected to pay a dividend of 0 USD.
Rezolute Dividend 2025
Rezolute Dividend
0 USD
Rezolute Dividend yield
Ticker
RZLT
ISIN
US76200L3096
How much dividend does Rezolute 2025 pay?
According to the latest status from April 2025, Rezolute paid a total of 0 USD per share in dividends within the last 12 months. With the current Rezolute price of 2.52 USD, this corresponds to a dividend yield of 0 %. A dividend is paid times per year.
| = |
Historical Rezolute Dividends
A dividend is paid times per year. Last year, the payout months were and .
| Paydate | Dividend |
|---|
Is the Rezolute Dividend Safe?
Rezolute has been increasing the dividend for 0 years.
Over the past 10 years, Rezolute has increased it by an annual 0 %.
Over a five-year period, the distribution increased by 0%.
Analysts expect a Dividend Cut of -100% for the current fiscal year.
Dividend Details
Understanding Rezolute's Dividend Distributions
Rezolute’s dividends are a portion of the company’s profits distributed to shareholders. It is a critical indicator of the company’s financial health and attractiveness to investors. Dividends provide investors with a steady income stream, in addition to any profits that may come from selling the stock at a higher price than the purchase price.
Year-to-Year Comparison
Examining Rezolute's dividend distributions over the years can highlight the company’s profitability and stability. A consistent or increasing dividend payout can indicate a financially healthy company with predictable earnings, while fluctuations or reductions in dividends can suggest underlying financial or operational challenges.
Impact on Investments
Rezolute's dividend payments are an essential factor for income-focused investors. A robust dividend payout can enhance the stock’s appeal, offering regular income in addition to potential capital gains. It also can indicate the company's confidence in its future earnings, making it a significant consideration in investment decisions.
Interpreting Dividend Fluctuations
Changes in Rezolute’s dividends can result from shifts in the company’s earnings, financial policies, or reinvestment strategies. An increase in dividends often signals financial stability, while a decrease may indicate a need to conserve cash or reinvest profits to fuel growth, each scenario having different implications for investors.
Rezolute Aktienanalyse
What does Rezolute do?
Rezolute Inc. is a bio-pharmaceutical company that was founded in 2010 in California. The company specializes in the research and development of innovative therapies for the treatment of rare metabolic and endocrine diseases. The business model of Rezolute is to develop innovative solutions and treatment approaches for diseases that currently have insufficient treatment options. The company is actively working to expand its product pipeline and explore new treatment methods in order to give hope and prospects for a better quality of life to suffering patients. Rezolute is active in three main areas: diabetes and metabolic diseases, diseases of the endocrine system, and protein-based therapy platforms. Each of these areas is of great importance in combating rare diseases that are often overlooked by the pharmaceutical industry. The diabetes and metabolic diseases category is the core business of Rezolute Inc. The company strives to develop innovative therapies for the treatment of diabetes itself and its comorbidities. This includes diseases of the cardiovascular system and kidney diseases, which are common among diabetes patients. In the category of endocrine diseases, the company is working on the development of targeted therapies for the treatment of diseases such as hypothyroidism (an underactive thyroid) and hypopituitarism (a deficiency of hormones produced by the pituitary gland). These diseases are often overlooked by the pharmaceutical industry as they occur less frequently compared to other diseases. The protein-based therapy platforms are technologically advanced and have the potential to offer new treatment options. Rezolute utilizes its own proprietary technologies for the development of immunoglobulins and drugs that specifically target certain molecules. The company is also researching compounds that can influence the immune system to combat inflammation and autoimmune diseases. Rezolute currently has several therapy options in development. The company is working on RZ358, an oral insulin formulation for the treatment of diabetes; RZ402, a drug for the treatment of pancreatitis (inflammation of the pancreas); and RZ402, a drug for the treatment of pancreatitis (inflammation of the pancreas). The company has also obtained orphan drug status to develop RZ358, its innovative therapy for the treatment of Congenital Hyperinsulinism (CHI), a rare, congenital endocrine disorder. Rezolute has established itself as an important player in the global bio-pharmaceutical market. The company is committed to improving the lives of patients suffering from rare diseases by developing innovative treatment options. With a dedicated team of scientists and researchers, the company strives to push the boundaries of science and develop the next generation of innovative therapies that have the potential to improve the lives of patients. Rezolute is one of the most popular companies on Eulerpool.com.Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Frequently Asked Questions about Rezolute stock
What is the dividend yield of Rezolute?
The current dividend yield of Rezolute is .
When does Rezolute pay dividends?
Rezolute pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Rezolute?
Rezolute paid dividends every year for the past 0 years.
What is the dividend of Rezolute?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Rezolute located?
Rezolute is assigned to the 'Health' sector.
Wann musste ich die Aktien von Rezolute kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Rezolute from 4/13/2025 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 4/13/2025.
When did Rezolute pay the last dividend?
The last dividend was paid out on 4/13/2025.
What was the dividend of Rezolute in the year 2024?
In the year 2024, Rezolute distributed 0 USD as dividends.
In which currency does Rezolute pay out the dividend?
The dividends of Rezolute are distributed in USD.
Andere Kennzahlen von Rezolute
Our stock analysis for Rezolute Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Rezolute Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
